Iteos TherapeuticsÂ Inc (ITOS) Financials

$10.15

$0.00 (0.00%)

As on 29-Aug-2025 09:30EDT

Market cap

$449 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	--	35.00	12.60	267.63	344.78	--
Cost of Revenue	0.63	1.24	0.90	0.81	0.62	0.54
Gross Profit	-35.01	33.76	11.70	266.82	344.16	-0.54
Operating Expenses	221.94	193.29	162.80	140.49	99.26	44.71
Operating Profit (EBIT)	-221.94	-159.53	-151.10	126.32	244.90	-45.24
Other Income	--	--	--	19.15	1.38	-0.05
Profit before Tax	-190.04	-120.34	-109.03	147.56	256.46	-38.38
Provision for Tax	11.88	14.07	3.61	52.08	41.94	-0.06
Profit after Tax (Net Income)	-202.41	-134.41	-112.64	96.65	214.52	-38.03
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	96.65	214.52	-43.40

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	493.80	590.29	575.23	663.33	552.82	323.20
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	59.01	56.32	52.35	49.66	27.77	6.36
Current Liabilities	70.27	40.36	40.01	42.00	304.12	15.00
Total Liabilities	693.36	686.98	667.59	754.99	884.71	344.56

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	94.09	177.44	116.94	126.69	10.00	5.01
Current Assets	528.99	509.54	550.65	628.30	874.71	339.54
Total Assets	693.36	686.98	667.59	754.99	884.71	344.56
Total Debt*	5.13	5.10	6.06	4.67	5.34	--
Net Current Assets	458.72	469.18	510.64	586.30	570.59	324.55

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-98.18	-103.76	-111.19	513.14	-25.18
Cash Flow from Investing Activities	--	-131.15	72.66	-446.06	-1.24	-0.38
Cash from Financing Activities	--	122.24	1.11	1.98	3.66	340.34
Net Cash Inflow / Outflow	--	--	--	-555.27	512.38	316.46

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-4.74	-3.32	-3.14	2.55	5.72	-1.56
Cash EPS ($)	--	-3.29	-3.12	2.57	5.74	-1.54
Adjusted Book Value ($)	--	14.58	16.05	17.51	14.75	13.27
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.43	-2.90	-2.94	13.69	-1.03
Free Cash Flow per Share ($)	--	-2.47	-2.98	-2.96	13.66	-1.05

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-22.85	-18.03	15.76	48.68	-22.10
ROE (%)	-37.34	-23.07	-18.19	15.89	48.98	-22.45
ROA (%)	-27.36	-19.85	-15.84	11.79	34.90	-20.27
EBIT Margin (%)	--	-351.60	-893.66	55.14	74.39	--
Net Margin (%)	--	-384.04	-894.34	33.70	61.97	79,235.42
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	1.78	-0.95	-0.22	--	--
EBIT Growth (%)	-78.09	-9.33	-176.28	-42.46	768.29	-71.82
Net Profit Growth (%)	-87.18	-19.33	-216.54	-54.95	664.04	-69.38
EPS Growth (%)	-58.01	-0.06	-2.23	-0.55	4.66	0.31
Book Value Growth (%)	-32.22	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-2.31	-3.48	7.65	8.14	-21.65
Price / Book Value	0.91	0.53	0.68	1.12	3.16	2.55
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.50	1.47	1.19	0.88	3.51	-12.87
Close Price ($)	9.97	7.68	10.95	19.53	46.56	33.82
High Price ($)	18.13	18.75	23.00	52.43	49.00	34.84
Low Price ($)	4.80	7.09	8.20	16.21	17.43	17.50
Market Cap ($ Cr)	448.68	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.01	0.01	0.01	0.01	--
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	--
Current Ratio	7.53	12.62	13.76	14.96	2.88	22.64
Quick Ratio	7.53	--	--	--	2.91	22.66
Interest Coverage	--	--	--	7.71	185.57	-31.53

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	10.55	51.61	0.91	3.51	--
Asset Turnover	--	0.05	0.02	0.33	0.56	--
Receivable days	--	53.18	129.56	9.91	6.58	--
Inventory Days	--	--	--	-4,531.26	-3,091.56	-221.88
Payable days	--	2,920.23	3,854.85	2,876.85	2,426.39	1,433.69
Cash Conversion Cycle	--	--	--	-7,398.19	-5,511.37	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.